Spero Therapeutics (SPRO)'s 30-day implied volatility (IV30) was 60.6% at the close on October 22, 2026, down from 67.3% the day before, against a 52-week range of 35.5% to 154.7%. Its 20-day historical volatility was 67.6%.
Data as of October 22, 2026.